Followers | 49 |
Posts | 1301 |
Boards Moderated | 0 |
Alias Born | 03/05/2014 |
Friday, July 25, 2014 10:05:58 PM
Of course, the upside of that would be a nice price on the buyout. Let's just say it's 1.50...it's almost a 5x multiple of now, and everyone makes money, some a lot. There is something to be said about "a bird in the hand." Conversely, if Elite gets their generics up and moving, in conjunction with an ART approval early-mid 2015, the sp will be far above 1.50, so many holding for this scenario don't see a takeover as a positive. Whatever--even a buyout scenario benefits from an increased sp...2.00 is better than 1.50. Thing is, once that first ART drug is approved, and they have 12+ more coming down the line, the price of buying Elite goes up exponentially. If you were a Pfizer, when would you want to buy, given the risk?
As an aside, personally, NH paying off the debt hit the nail on the head for me. Not only did he loan the company his own money, but took off the "going concern" out his own pocket. Money talks, and in this case loudly, given his reputation in the pharma field. Seen a lot of "promising" pharma/bio's come and go, with the company jonesing for dollars while they took huge salaries, making money riding it into the ground. If this isn't the opposite, I don't know what is. Ultimately, when I get depressed looking at the sp (and I do sometimes), I just think of this, the opioid market, and demand for ELTP's product, and go to sleep without the worry some stocks have caused me in the past.
GLTA--Maz
Recent ELTP News
- Form 8-K - Current report • Edgar (US Regulatory) • 08/27/2024 08:30:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2024 09:16:11 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 08:05:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/05/2024 08:07:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/20/2024 08:30:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2024 09:55:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/29/2023 07:21:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/26/2023 09:20:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 09:20:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/28/2023 12:05:38 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 11:58:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 11:50:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration with ZenaDrone • InvestorsHub NewsWire • 11/16/2023 12:32:07 PM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM